Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model
Authors
Keywords
Chemotherapy, Immune functions, Cytotoxic T cells, Immunotherapy, Cancer
Journal
BMC IMMUNOLOGY
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-20
DOI
10.1186/s12865-016-0167-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Towards a test to predict 5-fluorouracil toxicity: Pharmacokinetic data for thymine and two sequential metabolites following oral thymine administration to healthy adult males
- (2016) John A. Duley et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients
- (2015) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
- (2015) Shabnam Shalapour et al. NATURE
- Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
- (2015) David L. Chan et al. PLoS One
- Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation
- (2015) Huiru Wang et al. Oncotarget
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
- (2015) R. Winograd et al. Cancer Immunology Research
- Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
- (2015) Holly G. Prigerson et al. JAMA Oncology
- Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer
- (2014) Hanna K. Sanoff et al. JNCI-Journal of the National Cancer Institute
- Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study
- (2014) A. A. Wright et al. BMJ-British Medical Journal
- Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
- (2014) Gautier Stoll et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy
- (2013) A. J. Litterman et al. JOURNAL OF IMMUNOLOGY
- Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration
- (2013) Daniel Lucas et al. NATURE MEDICINE
- The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
- (2013) Sean M. Geary et al. PLoS One
- Immune effects of 5-fluorouracil
- (2013) François Ghiringhelli et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice
- (2012) Qing Sun et al. BMC Medicine
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
- (2012) C.-L. Chang et al. CANCER RESEARCH
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up
- (2010) Cornelis M. van Tilburg et al. BRITISH JOURNAL OF HAEMATOLOGY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- PD-1 on dendritic cells impedes innate immunity against bacterial infection
- (2009) S. Yao et al. BLOOD
- Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial Cells
- (2009) Andrea T. Hooper et al. Cell Stem Cell
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
- (2008) R. Nishimura et al. BLOOD
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More